Skip to main content Skip to navigation
BUV615 Mouse Anti-Human HLA-B7
Product Details
Down Arrow Up Arrow


BD OptiBuild™
HLA-B*07; HLAB7; MHC class I B7; MHC class I antigen B7
Human (Tested in Development)
Mouse IgG1, κ
Papain-solubilized Human HLA-B7
Flow cytometry (Qualified)
0.2 mg/ml
AB_2875106
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody.

Recommended Assay Procedures

BD™ CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to BD CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD CompBead to ensure that BD CompBeads are appropriate for your specific cellular application.

For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).

Note:  When using high concentrations of antibody, background binding of this dye to erythroid cell subsets (mature erythrocytes and precursors) has been observed.  For researchers studying these cell populations, or in cases where light scatter gating does not adequately exclude these cells from the analysis, this background may be an important factor to consider when selecting reagents for panel(s).

Product Notices

  1. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
  2. Researchers should determine the optimal concentration of this reagent for their individual applications.
  3. An isotype control should be used at the same concentration as the antibody of interest.
  4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  5. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
  6. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  7. BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.
  8. Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
  9. CF™ is a trademark of Biotium, Inc.
  10. BD Horizon Brilliant Ultraviolet 615 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.
751069 Rev. 2
Antibody Details
Down Arrow Up Arrow
BB7.1

The BB7.1 monoclonal antibody specifically recognizes the Human Leukocyte Antigen-B7 (HLA-B7) alpha subunit. The HLA-B7 alpha chain can noncovalently heterodimerize with β2-microglobulin to form a Major Histocompatibility Complex (MHC) class I B7 antigen that is involved in antigen presentation to CD8+ T cells or might serve as an NK cell receptor ligand. HLA-B7 is a serotype that identifies the more common HLA-B (HLA-B*07) encoded gene products which are expressed on nearly all nucleated cells of HLA-B7-positive individuals. B7 is a risk factor for cervical cancer, sarcoidosis, and some spondylarthropathies. The BB7.1 antibody can be used to distinguish false HLA-B27-positve staining when used in conjunction with some HLA-B27 antibodies that crossreact with HLA-B7. Although highly specific, the BB7.1 antibody can reportedly crossreact with HLA-B42 and HLA-B81 antigens.

The antibody was conjugated to BD Horizon BUV615 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome with an Ex Max near 350 nm and an Em Max near 615 nm. BD Horizon Brilliant BUV615 can be excited by the ultraviolet laser (355 nm) and detected with a 610/20 filter and a 595 nm LP.  Due to the excitation of the acceptor dye by the blue/yellow-green laser line, there may be significant spillover into channels detecting PE-CF594 like emissions (eg, 610/20-nm filter).

751069 Rev. 2
Format Details
Down Arrow Up Arrow
BUV615
The BD Horizon Brilliant™ Ultraviolet 615 (BUV615) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 615-nm. BUV615, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 615-nm (e.g, 610/20 bandpass filter). The acceptor dye can be excited by the Blue (488-nm) and yellow-green (561-nm) lasers resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
altImg
BUV615
Ultraviolet 355 nm
350 nm
615 nm
751069 Rev.2
Citations & References
Down Arrow Up Arrow

Development References (4)

  1. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979; 47:3-6. (Immunogen: Immunoaffinity chromatography, Radioimmunoassay). View Reference
  2. Hilton HG, Parham P. Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules.. Tissue Antigens. 2013; 81(4):212-20. (Clone-specific: Cytometric Bead Array). View Reference
  3. Parham P. Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns.. J Biol Chem. 1979; 254(18):8709-12. (Clone-specific: Immunoaffinity chromatography, Radioimmunoassay). View Reference
  4. Reches A, Nachmani D, Berhani O, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.. J Immunol. 2016; 196(12):4967-76. (Clone-specific: Flow cytometry). View Reference
View All (4) View Less
751069 Rev. 2

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.